Cooper Ronald Harold Wilfred - Net Worth and Insider Trading
Cooper Ronald Harold Wilfred Net Worth
The estimated net worth of Cooper Ronald Harold Wilfred is at least $3 Million dollars as of 2024-12-26. Cooper Ronald Harold Wilfred is the President and CEO of Albireo Pharma Inc and owns about 57,444 shares of Albireo Pharma Inc (ALBO) stock worth over $3 Million. Cooper Ronald Harold Wilfred is also the CEO of enGene Holdings Inc and owns about 10,000 shares of enGene Holdings Inc (ENGN) stock worth over $63,200. Details can be seen in Cooper Ronald Harold Wilfred's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Cooper Ronald Harold Wilfred has not made any transactions after 2024-09-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Cooper Ronald Harold Wilfred
Cooper Ronald Harold Wilfred Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Cooper Ronald Harold Wilfred owns 4 companies in total, including Genocea Biosciences Inc (GNCAQ) , Albireo Pharma Inc (ALBO) , and Generation Bio Co (GBIO) among others .
Click here to see the complete history of Cooper Ronald Harold Wilfred’s form 4 insider trades.
Insider Ownership Summary of Cooper Ronald Harold Wilfred
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| GNCAQ | Genocea Biosciences Inc | 2018-06-21 | director |
| ALBO | Albireo Pharma Inc | 2023-01-23 | director & President and CEO |
| GBIO | Generation Bio Co | 2021-03-01 | director |
 | | 2018-06-21 | director |
Cooper Ronald Harold Wilfred Latest Holdings Summary
Cooper Ronald Harold Wilfred currently owns a total of 2 stocks. Among these stocks, Cooper Ronald Harold Wilfred owns 57,444 shares of Albireo Pharma Inc (ALBO) as of January 23, 2023, with a value of $3 Million and a weighting of 97.57%. Cooper Ronald Harold Wilfred also owns 10,000 shares of enGene Holdings Inc (ENGN) as of September 27, 2024, with a value of $63,200 and a weighting of 2.43%.
Latest Holdings of Cooper Ronald Harold Wilfred
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ALBO | Albireo Pharma Inc | 2023-01-23 | 57,444 | 44.15 | 2,536,153 |
| ENGN | enGene Holdings Inc | 2024-09-27 | 10,000 | 6.32 | 63,200 |
Holding Weightings of Cooper Ronald Harold Wilfred
Cooper Ronald Harold Wilfred Form 4 Trading Tracker
According to the SEC Form 4 filings, Cooper Ronald Harold Wilfred has made a total of 6 transactions in Albireo Pharma Inc (ALBO) over the past 5 years, including 0 buys and 6 sells. The most-recent trade in Albireo Pharma Inc is the sale of 1,057 shares on January 23, 2023, which brought Cooper Ronald Harold Wilfred around $46,297.
According to the SEC Form 4 filings, Cooper Ronald Harold Wilfred has made a total of 1 transactions in enGene Holdings Inc (ENGN) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in enGene Holdings Inc is the acquisition of 10,000 shares on September 27, 2024, which cost Cooper Ronald Harold Wilfred around $57,000.
Insider Trading History of Cooper Ronald Harold Wilfred
- 1
Cooper Ronald Harold Wilfred Trading Performance
GuruFocus tracks the stock performance after each of Cooper Ronald Harold Wilfred's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cooper Ronald Harold Wilfred is -8.43%. GuruFocus also compares Cooper Ronald Harold Wilfred's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cooper Ronald Harold Wilfred within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Cooper Ronald Harold Wilfred's insider trading performs compared to the benchmark.
Performance of Cooper Ronald Harold Wilfred
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.27 | | | | | |
| Relative Return to S&P 500(%) | 15.97 | | | | | |
Cooper Ronald Harold Wilfred Ownership Network
Cooper Ronald Harold Wilfred Owned Company Details
What does Genocea Biosciences Inc do?
Who are the key executives at Genocea Biosciences Inc?
Cooper Ronald Harold Wilfred is the director of Genocea Biosciences Inc. Other key executives at Genocea Biosciences Inc include CHIEF LEGAL & COMPLIANCE OFF Jacquelyn L Sumer , director & President and CEO William D Clark , and CHIEF FINANCIAL OFFICER Diantha Duvall .
Genocea Biosciences Inc (GNCAQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Genocea Biosciences Inc (GNCAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Genocea Biosciences Inc (GNCAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Genocea Biosciences Inc (GNCAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Genocea Biosciences Inc Insider Transactions
Cooper Ronald Harold Wilfred Mailing Address
Above is the net worth, insider trading, and ownership report for Cooper Ronald Harold Wilfred. You might contact Cooper Ronald Harold Wilfred via mailing address: C/o Genocea Biosciences, Inc., 100 Acorn Park Drive, 5th Floor, Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
